BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17891347)

  • 1. Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case series.
    Komenda P; Zalunardo N; Burnett S; Love J; Buller C; Taylor P; Duncan J; Djurdjev O; Levin A
    Clin Exp Nephrol; 2007 Sep; 11(3):209-213. PubMed ID: 17891347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
    Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
    Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study.
    Wolak T; Aliev E; Rogachev B; Baumfeld Y; Cafri C; Abu-Shakra M; Novack V
    Isr Med Assoc J; 2013 Nov; 15(11):682-7. PubMed ID: 24511648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry.
    Fujihara M; Kawasaki D; Shintani Y; Fukunaga M; Nakama T; Koshida R; Higashimori A; Yokoi Y;
    Catheter Cardiovasc Interv; 2015 Apr; 85(5):870-7. PubMed ID: 25380326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.
    Nyman U; Almén T; Aspelin P; Hellström M; Kristiansson M; Sterner G
    Acta Radiol; 2005 Dec; 46(8):830-42. PubMed ID: 16392608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between serum creatinine and estimated glomerular filtration rate: implications for clinical practice.
    Nelson AW; Mackinnon B; Traynor J; Geddes CC
    Scott Med J; 2006 Nov; 51(4):5-9. PubMed ID: 17137139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy.
    Rosenstock JL; Bruno R; Kim JK; Lubarsky L; Schaller R; Panagopoulos G; DeVita MV; Michelis MF
    Int Urol Nephrol; 2008; 40(3):749-55. PubMed ID: 18438718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O; Cirit M; Yesil M; Bayata S; Tanrisev M; Varol U; Ersoy R; Esi E
    Nephrol Dial Transplant; 2007 Mar; 22(3):819-26. PubMed ID: 17090607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.
    Brar SS; Shen AY; Jorgensen MB; Kotlewski A; Aharonian VJ; Desai N; Ree M; Shah AI; Burchette RJ
    JAMA; 2008 Sep; 300(9):1038-46. PubMed ID: 18768415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of change in estimated glomerular filtration rate in patients with renal insufficiency after contrast-enhanced computed tomography: a case-control study.
    Bansal GJ; Darby M
    J Comput Assist Tomogr; 2009; 33(3):455-9. PubMed ID: 19478643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Vidt DG; Ridker PM; Monyak JT; Schreiber MJ; Cressman MD
    Clin Ther; 2011 Jun; 33(6):717-25. PubMed ID: 21704236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.
    Cirit M; Toprak O; Yesil M; Bayata S; Postaci N; Pupim L; Esi E
    Nephron Clin Pract; 2006; 104(1):c20-7. PubMed ID: 16685140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
    Maddirala S; Khan A; Vincent A; Lau K
    Am J Med Sci; 2008 Oct; 336(4):330-5. PubMed ID: 18854676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing emergent coronary procedures.
    Ueda H; Yamada T; Masuda M; Okuyama Y; Morita T; Furukawa Y; Koji T; Iwasaki Y; Okada T; Kawasaki M; Kuramoto Y; Naito T; Fujimoto T; Komuro I; Fukunami M
    Am J Cardiol; 2011 Apr; 107(8):1163-7. PubMed ID: 21349483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of renal artery atherosclerosis for renal salvage: does stenting help?
    Kashyap VS; Sepulveda RN; Bena JF; Nally JV; Poggio ED; Greenberg RK; Yadav JS; Ouriel K
    J Vasc Surg; 2007 Jan; 45(1):101-8; discussion 108-9. PubMed ID: 17210392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
    Jo SH; Koo BK; Park JS; Kang HJ; Cho YS; Kim YJ; Youn TJ; Chung WY; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2008 Mar; 155(3):499.e1-8. PubMed ID: 18294484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.